Blog
RSS FeedPosted by Michael Wonder on 09 Apr 2021
PBAC Public Summary Documents - December 2020 intracycle meeting
9 April 2021 - The Public Summary Documents (positive recommendations) from the December 2020 PBAC intracycle meeting are now available. ...
Posted by Michael Wonder on 06 Apr 2021
Agenda for the July 2021 PBAC meeting
6 April 2021 - How long will we have to wait for version 2? ...
Posted by Michael Wonder on 23 Mar 2021
PBAC publishes confusing Public Summary Document for tofacitinib citrate (Xeljanz)
24 March 2021 - The purpose of a public summary document is to provide to the public, information pertaining to a ...
Posted by Michael Wonder on 20 Mar 2021
PBAC Public Summary Documents (first time rejections and deferrals) - November 2020 meeting
19 March 2021 - The Public Summary Documents (first time rejections and deferrals) from the November 2020 PBAC meeting are now ...
Posted by Michael Wonder on 10 Mar 2021
PBAC updates Public Summary Document for medicine without a published outcome
11 March 2021 - The Department of Health has updated the Public Summary Document for adalimumab (Humira) from the July ...
Posted by Michael Wonder on 05 Mar 2021
PBAC Public Summary Documents - November 2020 meeting
5 March 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2020 PBAC ...
Posted by Michael Wonder on 23 Feb 2021
DoH updates agenda for March 2021 PBAC meeting
23 February 2021 - We are now up to version 5. ...
Posted by Michael Wonder on 15 Feb 2021
Post-market review of medicines for smoking cessation – stakeholder forum outcome
15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...
Posted by Michael Wonder on 15 Feb 2021
Agenda for the March 2021 PBAC meeting
15 February 2021 - A revised agenda for the March 2021 PBAC meeting is now available. ...
Posted by Michael Wonder on 20 Jan 2021
2021 April price disclosure cycle – indicative prices
20 January 2021 - Indicative 1 April 2021 prices resulting from the 2021 April Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 16 Jan 2021
PBAC Public Summary Documents (rejections/deferrals/other matters) - September 2020 intracycle meeting
15 January 2021 - The Public Summary Documents (rejections/deferrals/other matters) from the September 2020 PBAC untracycle meeting are now available. ...
Posted by Michael Wonder on 12 Jan 2021
Further insights from the agenda for the 2021/1 PBAC meeting
13 January 2021 - The case for improved clarity and transparency gets stronger. ...
Posted by Michael Wonder on 11 Jan 2021
DoH publishes revised agenda for March 2021 PBAC meeting
11 January 2021 - The initial agenda was revised within 24 hours of publication on the PBS website. ...
Posted by Michael Wonder on 21 Dec 2020
Closure of the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
21 December 2020 - A plain language summary for the post-market review of the use of biologics in the treatment ...
Posted by Michael Wonder on 18 Dec 2020
Recommendations made by the PBAC - November 2020
18 December 2020 - The recommendations from the November 2020 PBAC meeting are now available. ...